Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
07/2010
07/13/2010US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
07/13/2010US7754734 Administering one or more rapamycin derivatives (including rapamycin and 40-O-(2-hydroxy)ethyl-rapamycin); lymphocytic leukemia, lymphoma, Epstein-Barr virus, inhibiting graft rejection and metastasis; drug screening
07/13/2010US7754728 Adenine compound and use thereof
07/13/2010US7754228 Cytotoxic T-cell epitopes from Chlamydia
07/13/2010US7754205 Composition for transmucosal administration containing conenzyme Q as the active ingredient
07/13/2010CA2557536C Amino alcohol compound
07/13/2010CA2447030C Immune modulation device for use in animals
07/13/2010CA2446820C Novel pyrrole derivatives as pharmaceutical agents
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
07/13/2010CA2372443C Local administration of anti-malarial agents for the treatment of inflammatory diseases
07/13/2010CA2324289C Combined vaccine compositions
07/13/2010CA2286873C Dendritic cell hybrids
07/09/2010CA2648602A1 Method of treating pregnant cows and/or heifers
07/08/2010WO2010078543A1 Tablet containing cetirizine pseudoephedrine, and naproxen containing a barrier layer
07/08/2010WO2010078542A1 Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
07/08/2010WO2010078541A1 Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
07/08/2010WO2010078526A1 Anti-lymphotoxin antibodies
07/08/2010WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010WO2010076879A1 Sulfated c-glycoside, method for isolating same and method for synthesizing same
07/08/2010WO2010076583A1 A variant of mite allergen and uses thereof
07/08/2010WO2010076537A1 Immunoglobulin g composition
07/08/2010WO2010055304A3 Oxazole or imidazole derivatives for use in the treatment of autoimmune disesases, in particular multiple sclerosis
07/08/2010WO2010055028A3 Crystalline forms of fingolimod hcl
07/08/2010WO2010053902A3 Tryptase enzyme inhibiting aminothiophenols
07/08/2010WO2010051634A9 Human progenitor t-cells
07/08/2010WO2010049451A3 C-glycosidic analogues of alpha-galactosylceramids having immunostimulating and immunoregulating properties
07/08/2010WO2010049144A3 Ligands for modulation of orphan receptor-gamma (nr1f3 ) activity
07/08/2010WO2010045431A3 Dry powder formulations, vaccines and methods
07/08/2010WO2010041143A3 Oral vaccines for producing mucosal immunity
07/08/2010WO2010039742A3 Methods to reduce b-helper t cells to treat autoimmune diseases
07/08/2010WO2010036876A3 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
07/08/2010WO2010027189A3 A new use for homoisoflavanone or a salt thereof
07/08/2010US20100174076 Coumarin derivatives useful as tnf alpha inhibitors
07/08/2010US20100174056 Recombinant tumor specific antibody and use thereof
07/08/2010US20100173955 4-substituted phenoxyphenylacetic acid derivatives
07/08/2010US20100173949 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
07/08/2010US20100173916 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
07/08/2010US20100173908 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
07/08/2010US20100173885 Organometeallic compounds
07/08/2010US20100173881 Compositions for the treatment of inflammatory disorders
07/08/2010US20100173878 Organic compounds
07/08/2010US20100173854 Microfluidized Oil-in-water Emulsions and Vaccine Compositions
07/08/2010US20100173851 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
07/08/2010US20100173848 Methods of inhibiting chemokine binding to chemokines receptors
07/08/2010US20100173840 Pharmaceutical Composition for Treating Autoimmune, Allergic and Inflammatory Diseases and Delivery Method Thereof
07/08/2010US20100173838 Novel process for the preparation of cyclosporin derivatives
07/08/2010US20100173823 Alpha2c adrenoreceptor agonists
07/08/2010US20100173413 Pyridine compounds
07/08/2010US20100173327 Nonhuman model animal lacking the ability to control lymphocyte migration
07/08/2010US20100173020 Uses of ammonium chloride
07/08/2010US20100173013 Treatment of neoplastic disorders using combination therapies
07/08/2010US20100173002 Microcapsules with improved shells
07/08/2010US20100172992 Pathogenic attenuation via the administration of an equilibiotic compound
07/08/2010US20100172985 Tablet Containing Cetirizine, Pseudoephedrine, and Naproxen Containing a Barrier Layer
07/08/2010US20100172984 tablet dosage form comprising cetirizine and pseudoephedrine
07/08/2010US20100172980 Tablet Containing Coated Particles of Cetirizine, Pseudoephedrine, and/or Naproxen
07/08/2010US20100172971 Compositions for Inhibiting NADPH Oxidase Activity
07/08/2010US20100172966 Methods and compositions for cellular reprogramming
07/08/2010US20100172962 Therapeutic targeting of interleukins using sirna in neutral liposomes
07/08/2010US20100172938 Modified bacterial surface layer proteins
07/08/2010US20100172935 Method for viral inoculation of the vestibular region of the nares
07/08/2010US20100172933 Recombinant vectors based on the modified vaccinia ankara (mva) virus as vaccines against lieshmaniasis
07/08/2010US20100172932 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes
07/08/2010US20100172930 Transfection complexes
07/08/2010US20100172925 Hla-a2-restricted t-cell epitopes of the respiratory syncytial virus fusion protein as peptide-based vaccines
07/08/2010US20100172923 Protein Composition for Inducing an Immune Response in a Vertebrate Comprising a Plurality of Protein Variants Covering the Heterogeneity of a Single Antigen, AMA1
07/08/2010US20100172917 Binding molecules against SARS-coronavirus and uses thereof
07/08/2010US20100172912 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
07/08/2010US20100172905 Antagonists of hmg1 for treating inflammatory conditions
07/08/2010US20100172902 Method for treating a vcam-1 mediated disease
07/08/2010US20100172878 Polynucleotides encoding mhc class i-restricted htert epitopes, analogues thereof or polyepitopes
07/08/2010US20100172862 Stable antibody compositions and methods of stabilizing same
07/08/2010CA2781805A1 Chlamydia antigens and uses thereof
07/08/2010CA2771681A1 Immunoglobulin g composition
07/08/2010CA2750196A1 Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
07/08/2010CA2748783A1 Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
07/08/2010CA2748757A1 Anti-lymphotoxin antibodies
07/08/2010CA2748729A1 Sulfated c-glycoside, method for isolating same and method for synthesizing same
07/08/2010CA2748728A1 Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
07/08/2010CA2746228A1 Modified rsv f proteins and methods of their use
07/08/2010CA2746221A1 Isoindolinone and related analogs as sirtuin modulators
07/07/2010EP2204452A1 Modified Vaccinia Ankara Virus variant
07/07/2010EP2204189A2 Allergen peptide fragments and use thereof
07/07/2010EP2204186A1 Immunogenic complexes and methods relating thereto
07/07/2010EP2204181A2 Protease inhibitors
07/07/2010EP2204171A1 Use of glucocorticoid receptor antagonists for treatment of infectious conditions
07/07/2010EP2203429A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors
07/07/2010EP1663217B1 Solid dispersions comprising tacrolimus
07/07/2010EP1491537B1 Hydroxymorpholinone derivative and medicinal use thereof
07/07/2010EP1485099B1 Inhibitors of histone deacetylase
07/07/2010EP1470218B1 Corona-virus-like particles comprising functionally deleted genomes
07/07/2010EP1334201B1 Dna expression vectors
07/07/2010EP1079862B1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
07/07/2010EP0979284B2 Reagents for vaccination which generate a cd8 t cell immune response
07/07/2010CN1942469B Condensed pyridine derivatives useful as A28 adenosine receptor antagonists
07/07/2010CN101772571A Composition comprising lactic acid bacterium having high anti-allergic activity, and method for production of the lactic acid bacterium
07/07/2010CN101768565A Bacillus anthracis capable of displaying PAD4 protein on surface of spore and application thereof
07/07/2010CN101768215A House lizard glycopeptide, method for preparing same and medicinal application thereof
07/07/2010CN101768152A Piperidine derivatives useful as CCR5 antagonists
1 ... 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 ... 1172